Transfusion Savings in Heart Surgery: Impact of Individual Strategy by Erythropoietin and Metabolic Adjustment (ScvO2)

NCT04141631 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Surgery
Transfusion
Perioperative Anemia

Interventions

DRUG: EPO (600UI/Kg, sub-cutaneous) and Ferric Carboxymaltose (FCM) (20 mg/kg in 250 mL of saline solution 0.9% over 15 min)

Sponsor

University Hospital, Montpellier